Showing results (941-950 of 1,074) with videos related to

Sort By:
Pageof 108
Frontiers in Immunology|December 26, 2017
Multidimensional Analysis Integrating Human T-Cell Signatures in Lymphatic Tissues with Sex of Humanized Mice for Prediction of Responses after Dendritic Cell ImmunizationValery Volk, Andreas I Reppas, Philippe A Robert, et al.
Nucleic Acid Therapeutics|March 1, 2019
IONIS-PKKRx a Novel Antisense Inhibitor of Prekallikrein and Bradykinin ProductionJason D Ferrone, Gourab Bhattacharjee, Alexey S Revenko, et al.
Circulation. Arrhythmia and Electrophysiology|November 18, 2022
Early Catheter Ablation Versus Initial Medical Therapy for Ventricular Tachycardia StormKaimin Huang, Richard G Bennett, Timothy Campbell, et al.
Pediatric Research|December 14, 1999
Identification of new prognosis factors from the clinical and epidemiologic analysis of a registry of 229 Diamond-Blackfan anemia patients. DBA group of Société d'Hématologie et d'Immunologie Pédiatrique (SHIP), Gesellshaft für Pädiatrische Onkologie und Hämatologie (GPOH), and the European Society for Pediatric Hematology and Immunology (ESPHI)T N Willig, C M Niemeyer, T Leblanc, et al.
Optics Express|October 24, 2013
Single shot speckle and coherence analysis of the hard X-ray free electron laser LCLSSooheyong Lee, W Roseker, C Gutt, et al.
ESMO Open|June 22, 2026
Sex-based differences in tolerability of developmental antibody-drug conjugates (ADCs) in non-small-cell lung cancer (NSCLC)C Parisi, M Banini, F Mantuano, et al.
Cell Reports|June 11, 2020
Vangl2 in the Dentate Network Modulates Pattern Separation and Pattern CompletionBenjamin J A Robert, Maïté M Moreau, Steve Dos Santos Carvalho, et al.
Physical Review Letters|February 14, 2012
Single shot spatial and temporal coherence properties of the SLAC Linac Coherent Light Source in the hard x-ray regimeC Gutt, P Wochner, B Fischer, et al.
Bioorganic & Medicinal Chemistry Letters|November 10, 2009
N3-arylmalonamides: a new series of thieno[3,2-b]pyridine based inhibitors of c-Met and VEGFR2 tyrosine kinasesOscar Saavedra, Stephen Claridge, Lijie Zhan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 2009
Phase I study of MG98, an oligonucleotide antisense inhibitor of human DNA methyltransferase 1, given as a 7-day infusion in patients with advanced solid tumorsRuth Plummer, Laura Vidal, Melanie Griffin, et al.
Pageof 108